Research
Hormonal
GLP-1 receptor agonists enhance insulin secretion, support weight loss, and exhibit neuroprotective and cardiovascular benefits.
Practitioners can consider GLP-1 receptor agonists for their multifaceted benefits in diabetes management.
StrongSupportsmedium confidence
GLP-1 receptor agonists enhance insulin secretion, support weight loss, and exhibit neuroprotective and cardiovascular benefits.
Why this rating
The review summarizes findings from multiple studies.
Source
A comprehensive review of the multisystem benefits of antidiabetic drugs in aging beyond glycemic control
Fatema Tuz Zohora et al. · Translational Medicine of Aging · 2025
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →